You just read:

Genoa Pharmaceuticals and McMaster University demonstrate inhaled pharmacokinetics enables improved pirfenidone activity with significant promise to enhance IPF treatment safety and tolerability

News provided by

Genoa Pharmaceuticals

Apr 21, 2014, 12:01 ET